| Authors | Differentiation factors | Differentiation period | Starting iPSC type | Induced cell type |
| Morizane et al. 2009 [56] | Activin A, GDNF, BMP7 | 14 days or 18 days | Murine iPSC | Tubular cells, metanephric mesenchyme cells | Song et al. 2012 [57] | Activin A, BMP7, and RA | 10 days | Human iPSC | Podocyte-like cells | Mae et al. 2013 [58] | CHIR99021, Activin A, and BMP7 | ~10 to 20 days | OSR1-GFP human iPSC | Intermediate mesoderm cells | Xia et al. 2013 [59] | BMP4, FGF2, RA, activin A, and BMP2 | 4 days | Human iPSC | Ureteric bud kidney progenitor-like cells | Taguchi et al. 2014 [60] | BMP4, activin A, basic FGF, CHIR RA, and FGF9 | 14 days | Human iPSC | Kidney organoid—Metanephric nephron progenitors | Araoka et al. 2014 [61] | CHIR99021 and AM580 or TTNPB | 5 days | Human iPSC and OSR1-GFP human iPSC | Intermediate mesoderm cells | Lam et al. 2014 [62] | CHIR99021, FGF2, RA, FGF9, and activin A | 9 days | Human iPSC | Intermediate mesoderm cells | Kang & Han 2014 [63] | Activin A, Wnt3a, BMP4, FGF2, RA, BMP7 | 26 days | Human iPSC | Nephron progenitor cells | Imberti et al. 2015 [64] | RA, RhoA inhibitor and PI3K inhibitor, activin A, FGF2, BMP7, and GDNF | 19 days | Human iPSC | Renal progenitor cells | Toyohara et al. 2015 [65] | Activin A, CHIR, BMP7, TTNPB, TGF-β1, and DMH1 | 28 days | Human iPSC | Renal progenitor cells | Li et al. 2015 [66] | RA, BMP7, activin A, renal epithelial cell growth medium alone | 10 days | Mouse iPSC | Renal progenitor cells | Kandasamy et al. 2015 [67] | Renal epithelial growth medium, Rho kinase, BMP2, and BMP7 | 8 days | Human iPSC | Proximal tubular-like cells | Takasato et al. 2015 [68, 69] | CHIR, FGF9, heparin | 25 days | Human iPSC | Kidney organoid–nephron segment cells | Morizane et al. 2015 [70] | FGF2, CHIR, Noggin, activin A, and FGF9 | 9 days (NPCs) 21-35 days (organoids) | Human iPSC | Kidney organoid–nephron progenitor cells and nephron epithelia | Freedman et al. 2015 [71] | CHIR and B27 | 16–23 days | Human iPSC | Kidney organoid–nephron segment cells | Ciampi et al. 2016 [72] | N2 and B27 supplements, CP21R7 (Roche), BMP4, retinoic acid, BMP7, FGF9, vitamin D3 | 13 days | Human iPSC | Podocyte-like cells | Musah et al. 2017 [73] | Activin A, CHIR, BMP7, VEGF, and retinoic acid | 26 days | Human iPSC | Podocyte-like cells | Taguchi & Nishinakamura 2017 [74] | Activin, Bmp4, CHIR, FGF9, FGF1, GDNF, LDN193189, SB431542, retinoic acid, and B27 | 12.5 days | Human iPSC | Ureteric bud-like cells | Wu et al. 2018 [75] | CHIR, FGF9, heparin, Noggin, activin, and NTRK2 inhibitor K252a | 25–26 days | Human iPSC | Kidney organoid–nephron progenitor cells | Przepiorski et al. 2018 [76] | CHIR and KnockOut Serum Replacement (KOSR) | 14–26 days | Human iPSC | Kidney organoid–nephron progenitor cells | Rauch et al. 2018 [77] | Activin A, BMP7, and retinoic acid | 10 days | Human iPSC | Podocyte-like cells | Mae et al. 2018 [78] | Activin A, CHIR, BMP4, LDN193189, A83-01, retinoic acid, PD0325901, FGF8, TTNPB, GDNF, FGF1, thiazovivin | 15 days | Human iPSC | Wolffian duct cells | Qian et al. 2019 [79] | CHIR and B27 | 16 days | Human iPSC | Podocyte-like cells | Hariharan et al. 2019 [80] | Activin A, BMP4, retinoic acid, GDNF, HGF, REGM, FGF2, and BMP7 | 6 - 14 days | Human iPSC | Renal progenitor cell–multiple nephronal cell | Ahmadi et al. 2019 [81] | CHIR, PD032590, activin A, TTNPB, BMP7, LIF, GDNF, retinoic acid, vitamin D3, dexamethasone | 22 days | Mouse iPSC | Podocyte-like cells | Garreta et al. 2019 [82] | CHIR, FGF9, heparin, activin A | 21 days | Human iPSC | Kidney organoid–nephron segment cells |
|
|